Andrew Kimmel

Partner at Knobbe Martens

Andrew Kimmel is a Partner at Knobbe Martens Olson & Bear LLP, a position held since September 2002. Prior to this, Andrew served as VP of Engineering & Regulatory Affairs at Biolase Technology from 1991 to 2002, where responsibilities included the development of advanced dental laser technologies, intellectual property strategy and management, as well as overseeing FDA clearances and compliance. Andrew holds a Juris Doctor degree from the University of San Diego School of Law, obtained between 1999 and 2002, and a Bachelor of Science degree in Electrical Engineering from Cornell University, earned from 1987 to 1991.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Knobbe Martens

2 followers

Our firm boasts IP law’s largest and most experienced biotechnology group, with more than 60 attorneys and scientists representing clients in all stages of their business and technology development. Our clients are innovators in a variety of disciplines including PCR, molecular tools and probes, immunology (antibodies and other binding proteins), cell varieties and uses (including stem cells) and biological polymers, to name but a few. Our expertise across the entire biotech landscape gives us great insight into specific technologies, systems and markets. More importantly, our holistic understanding of the interrelated technologies and systems typically involved in a single invention allows us to provide coordinated guidance and counsel from inception though introduction. Working in collaboration with more than 300 IP firms worldwide, we effect patent, trademark, copyright, and other filings, and direct oppositions, cancellations, and litigation matters in over 120 countries. We have considerable experience in negotiating and drafting traditional licensing agreements as well as agreements for strategic alliances, partnerships and joint ventures. We also maintain a talented litigation department adept in all aspects of biotechnology IP law, including the Biosimilars legislation. Our extensive Hatch-Waxman litigation experience combined with our understanding of the biotechnology industry uniquely positions Knobbe Martens to help clients develop and implement litigation strategies designed to maximize their place in the Biosimilars market place. In addition, we have considerable experience litigating before the U.S. Court of Appeals for the Federal Circuit and the International Trade Commission. Our attorneys have experience in all areas of Biotechnology, including: Aesthetic & Cosmetic Biotechnology Antibodies & Immunology Biofuels Biological Manufacturing Of Chemicals Biologics Diagnostic Tools Genomics Industrial Enzymes Peptides Personalized Medicine Research Tools & Reagents Stem Cells & Regenerative Medicine Synthetic Biology & Nanotechnology Therapeutics Tissue Engineering Transgenic Animals Vaccines


Industries

Employees

501-1,000

Links